Publications by authors named "H D Hunger"
Article Synopsis
- This study investigated how lower extremity manipulation affects the stability of standing on an inclined surface in healthy individuals.
- The research included eight participants who stood on an incline for 3 minutes to create a sensory illusion and then experienced either joint manipulation or no intervention.
- Results showed significant differences in the center of pressure (CoP) between the intervention and control conditions, indicating that extremity manipulation can improve postural stability, potentially influencing clinical practices for populations with stability issues.
Aripiprazole versus other atypical antipsychotics for schizophrenia.
Cochrane Database Syst Rev
February 2013
Background: In most western industrialised countries, second generation (atypical) antipsychotics are recommended as first line drug treatments for people with schizophrenia. In this review we specifically examine how the efficacy and tolerability of one such agent - aripiprazole - differs from that of other comparable second generation antipsychotics.
Objectives: To evaluate the effects of aripiprazole compared with other atypical antipsychotics for people with schizophrenia and schizophrenia-like psychoses.
Risperidone versus other atypical antipsychotics for schizophrenia.
Cochrane Database Syst Rev
January 2011
Background: In many countries of the industrialised world second-generation ("atypical") antipsychotics (SGAs) have become the first line drug treatment for people with schizophrenia. The question as to whether and if so how much the effects of the various SGAs differ is a matter of debate. In this review we examined how the efficacy and tolerability of risperidone differs from that of other SGAs.
View Article and Find Full Text PDFClozapine versus other atypical antipsychotics for schizophrenia.
Cochrane Database Syst Rev
November 2010
Background: Clozapine is an atypical antipsychotic demonstrated to be superior in the treatment of refractory schizophrenia which causes fewer movement disorders. Clozapine, however, entails a significant risk of serious blood disorders such as agranulocytosis which could be potentially fatal. Currently there are a number of newer antipsychotics which have been developed with the purpose to find both a better tolerability profile and a superior effectiveness.
View Article and Find Full Text PDFZotepine versus other atypical antipsychotics for schizophrenia.
Cochrane Database Syst Rev
October 2010
Background: In many parts of the world, particularly in industrialised countries, second generation (atypical) antipsychotic drugs have become first line treatment for people suffering from schizophrenia. The question as to whether the effects of various second generation antipsychotic drugs differ is a matter of debate.
Objectives: To evaluate the effects of zotepine compared with other second generation antipsychotic drugs for people suffering from schizophrenia and schizophrenia-like psychoses.